报价延迟最少15分钟:2025/08/18 02:51 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.59 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.56/-0.92
|
|
企业价值
1.41B
|
| 资产负债 |
|
每股账面净值
3.37
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
28.83M
|
|
每股收益
0.17
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/18 02:51 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program. |
